Expanded Indication for DIACOMIT® (stiripentol)!

Approved for children 6 months and up!

DIACOMIT is the only FDA-approved antiseizure medication specifically for seizures associated with Dravet syndrome in children as young as 6 months. It is indicated for patients weighing 15 pounds or more and taking clobazam.

Access DIACOMIT®(stiripentol)

Access DIACOMIT for your patients in three steps.

Biocodex has partnered with a specialty pharmacy that will manage the process and deliver DIACOMIT directly to your patient’s door. With this checklist, you can keep track of forms and information the pharmacy needs to fill your patient’s prescription.

Download the checklist today.

*Required Fields
By opting in, I confirm that I am a healthcare provider and understand that the information I have provided will be used by Biocodex, Inc. and contracted third parties to contact me with relevant information in accordance with the Biocodex Privacy Policy. I may opt out by following the instructions outlined in the Privacy Policy.
I agree*

BBD-00219-032023

IMPORTANT SAFETY INFORMATION

CONTRAINDICATIONS None

WARNINGS & PRECAUTIONSSomnolence DIACOMIT can cause somnolence. Monitor patients for somnolence, particularly when DIACOMIT is used concomitantly with other CNS depressants or clobazam, which is also known to cause somnolence.

Read All